Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSES: Neuroendocrine Sensitivity in Social Decisions
NCT06018727Phase 4Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Goal-directed decision-making in the Social Decision Tree Task (SDTT) at Day 7, Change in salivary cortisol at Day 7 and 1 more. Planned start Jul 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT06018727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06018727.